Earlier today, the FDA approved esketamine (brand name Spravato), a chemical twin of the dissociative psychedelic/anaesthetic ketamine (Special K), as a treatment for depression. Spravato comes in nasal spray form meant to be administered weekly or every other week depending on the severity of the patient's depression.
"There has been a longstanding need for additional effective treatments for treatment-resistant depression, a serious and life-threatening condition," said the FDA's acting director of the Division of Psychiatry Products, Dr. Tiffany Farchione, in a press release. "Because of [safety] concerns, the drug will only be available through a restricted distribution system and it must be administered in a certified medical office where the health care provider can monitor the patient."
From National Public Radio:
Many doctors who have become comfortable offering ketamine for depression probably won't switch to esketamine, said Dr. Demitri Papolos, director of research for the Juvenile Bipolar Research Foundation and a clinical associate professor at Albert Einstein College of Medicine.
For the past 10 years, Papolos has been prescribing an intranasal form of ketamine for children and adolescents who have a disorder that includes symptoms of depression.
"I'm very pleased that finally the FDA has approved a form of ketamine for treatment-resistant mood disorders," Papolos said. He said the approval legitimizes the approach he and other doctors have been taking.
But he hopes that doctors who are currently using ketamine continue to do so. "It'll be a lot less expensive and a lot easier for their patients [than esketamine]," he said.
And animal studies show it's possible that old-fashioned ketamine is a more potent antidepressant than esketamine, Papolos said.
Esketamine "may not be as effective as a generic that any psychiatrist or physician can prescribe without restrictions," Papolos said.
Previously on Boing Boing:
• Dissociative psychedelic Ketamine may help suicidal children
• Report: Ketamine aids the chronically depressed
• Ketamine helps depressed patients temporarily experience pleasure again
Listening to people talk about their drug trips usually isn’t very interesting but a new Netflix documentary proves that listening to FAMOUS people talk about theirs is. HAVE A GOOD TRIP: ADVENTURES IN PSYCHEDELICS is a documentary featuring comedic tripping stories from A-list actors, comedians, and musicians. Star-studded reenactments and trippy animations bring their surreal […]
“I feel so brain dead I can’t even speak.” Find out what happens when two editors from Popular Science quit their six-cup-a-day coffee habit for two weeks. From the YouTube description: Caffeine is the most widely used psychoactive drug on the planet. Like all good things in this world, it should be consumed in moderation—but […]
You’ve probably received spam emails inviting you to join class action lawsuits against the makers of over-the-counter heartburn medicine Zantac (ranitidine) as it contains a likely carcinogen. Today, the US Food and Drug Administration requested that all ranitidine products be pulled from store shelves and that consumers properly dispose of any they’ve already purchased. You […]
Hunting around for an outlet or a power battery when you’re trying to charge your phone or tablet is always an annoyance. But when you’re out in the world hiking or camping or traveling, finding an outlet might be more than a minor inconvenience…it might be downright impossible. Running low on battery power isn’t an […]
“Live as if you were to die tomorrow. Learn as if you were to live forever” – Mahatma Gandhi Of all the skills you feel like you should probably know, yet likely don’t, coding might be one of the most intimidating. From the varied programming languages to the range of platforms to the sheer discomfort […]
Even though it feels like Amazon is a singular retail juggernaut crushing everybody else, you might be surprised to learn that half of Amazon’s $280 billion in revenue last year came from third-party sellers. According to numbers compiled by JungleScout, 86 percent of Amazon’s Fulfilled by Amazon (FBA) sellers were profitable last year, more than […]